PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+21.71%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.7B
AUM Growth
+$1.7B
(+27%)
Cap. Flow
+$87.2M
Cap. Flow
% of AUM
5.12%
Top 10 Holdings %
Top 10 Hldgs %
66.83%
Holding
48
New
5
Increased
24
Reduced
10
Closed
2
Top Buys
| 1 |
WMGI
Wright Medical Group Inc
WMGI
|
$32.4M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$21.3M |
| 3 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$16.2M |
| 4 |
United Therapeutics
UTHR
|
$13.5M |
| 5 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$13.1M |
Top Sells
| 1 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$54.4M |
| 2 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
$18.2M |
| 3 |
Exact Sciences
EXAS
|
$10.6M |
| 4 |
Geron
GERN
|
$2.32M |
| 5 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$1.55M |
Sector Composition
| 1 | Healthcare | 57.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
United Therapeutics
UTHR
$13.8B
| $182M | 10.67% | 1,403,128 +104,300 | +8% | +$13.5M |
|
|
AUXL
2
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $169M | 9.92% | 4,915,931 +61,300 | +1% | +$2.11M |
|
|
CBST
3
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $131M | 7.7% | 1,303,668 -540,020 | -29% | -$54.4M |
|
|
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
| $118M | 6.91% | 2,102,857 +381,100 | +22% | +$21.3M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $118M | 6.91% | 1,302,197 +37,800 | +3% | +$3.42M |
|
|
ABMD
6
DELISTED
Abiomed Inc
ABMD
| $93.6M | 5.5% | 2,460,124 +30,600 | +1% | +$1.16M |
|
|
CYBX
7
DELISTED
CYBERONICS INC
CYBX
| $89.5M | 5.26% | 1,608,101 -13,000 | -0.8% | -$724K |
|
|
AMAG
8
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $85M | 4.99% | 1,994,200 +379,664 | +24% | +$16.2M |
|
|
ANAC
9
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $81.3M | 4.77% | 2,521,822 +405,157 | +19% | +$13.1M |
|
10
Insmed
INSM
$28.8B
| $71.6M | 4.2% | 4,625,648 +733,449 | +19% | +$11.3M |
|
|
WMGI
11
DELISTED
Wright Medical Group Inc
WMGI
| $54.8M | 3.22% | 2,039,751 +1,207,022 | +145% | +$32.4M |
|
12
Vanda Pharmaceuticals
VNDA
$279M
| $54.2M | 3.18% | 3,786,908 +503,784 | +15% | +$7.21M |
|
|
NPSP
13
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $42.6M | 2.5% | 1,190,263 -509,299 | -30% | -$18.2M |
|
|
KYTH
14
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $38.9M | 2.28% | 1,121,884 +19,703 | +2% | +$683K |
|
|
SQNM
15
DELISTED
SEQUENOM INC NEW
SQNM
| $36.7M | 2.16% | 9,925,742 +115,300 | +1% | +$427K |
|
|
EIGR
16
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $27.4M | 1.61% | 1,403,800 -53,400 | -4% | -$1.04M |
|
|
CELG
17
DELISTED
Celgene Corp
CELG
| $24.1M | 1.42% | 215,500 +43,900 | +26% | +$4.91M |
|
18
STAAR Surgical
STAA
$1.36B
| $24M | 1.41% | 2,629,622 +30,069 | +1% | +$274K |
|
19
Gilead Sciences
GILD
$140B
| $22.1M | 1.3% | 234,600 +67,100 | +40% | +$6.32M |
|
|
SHPG
20
DELISTED
Shire pic
SHPG
| $18.2M | 1.07% | 85,600 +21,900 | +34% | +$4.65M |
|
|
MNTA
21
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $17.5M | 1.03% | 1,455,176 | – | – |
|
|
ALIM
22
DELISTED
Alimera Sciences, Inc.
ALIM
| $16.7M | 0.98% | 3,013,793 -26,467 | -0.9% | -$147K |
|
23
Amicus Therapeutics
FOLD
$2.34B
| $16.3M | 0.96% | 1,956,376 | – | – |
|
|
MDVN
24
DELISTED
MEDIVATION, INC.
MDVN
| $16.1M | 0.94% | 161,300 +31,200 | +24% | +$3.11M |
|
|
ARIA
25
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $15.3M | 0.9% | 2,231,717 | – | – |
|